日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

维洛沙嗪在中枢神经系统疾病治疗中的应用:历史回顾与现状

Findling, Robert L; Candler, Shawn A; Nasser, Azmi F; Schwabe, Stefan; Yu, Chungping; Garcia-Olivares, Jennie; O'Neal, Welton; Newcorn, Jeffrey H

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder

缓释丁丙诺啡(RBP-6000)可阻断阿片类药物使用障碍患者接受氢吗啡酮激发试验后产生的反应。

Nasser, Azmi F; Greenwald, Mark K; Vince, Bradley; Fudala, Paul J; Twumasi-Ankrah, Philip; Liu, Yongzhen; Jones, J P 3rd; Heidbreder, Christian

Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1

针对脑膜炎奈瑟菌B群和大肠杆菌K1荚膜多糖的保护性人免疫球蛋白M抗体的可变区序列和独特型表达

Azmi, F H; Lucas, A H; Raff, H V; Granoff, D M